The U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet
Category: Treatment
Technology for accelerated wound healing
Researchers at Uppsala University and SLU have found a new way of accelerating wound healing. The technology involves using lactic
Xepi for treating Impetigo
Xepi (ozenoxacin) is a topical non-fluorinated quinolone for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes. Xepi
Sublocade for treating opioid use disorder
Food and Drug Administration has approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use
Digital scan of the eyes reveals health condition
In terms of diagnostic imaging, the eye is a unique part of the human body. Using optical coherence tomography OCT
Progesterone does not prevent preterm birth
Progesterone pessaries are sometimes prescribed to pregnant women who have previously given birth before 37 weeks, who have risk of
Killer peptide for killing cancer cells
Death of therapy sensitive cancer cells leads to the release of a killer peptide that can eliminate therapy resistant cells.
When allergies are out of control
Allergens are foreign substances that cause an allergic reaction in the body, allergy symptoms occur when immune system overreacts to
Ovarian freezing is better than eggs freezing
Freezing of ovaries preserve fertility better than eggs. Women who freezed their ovaries tissues can have babies easily in future.
Facts about glaucoma
There are an estimated 64 million people worldwide with glaucoma, a group of eye conditions in which the main nerve
